Cisapride and dexamethasone in the prevention of delayed emesis after cisplatin administration

Supportive Care in Cancer

Volumn 9, Issue 1, 2001, Pages 61-64

  Maisano, Roberto ^a,c   Spadaro, Pietro ^a   Toscano, Giuseppe ^a   Caristi, Nicola ^b   Pergolizzi, Stefano ^b   Salimbeni, Vincenzino ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c Università degli Studi ^*  (Italy)

Author keywords

Cisapride; Cisplatin; Delayed emesis

Indexed keywords

CISAPRIDE; CISPLATIN; DEXAMETHASONE; ONDANSETRON;

ABDOMINAL CRAMP; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EPIGASTRIC PAIN; FEMALE; HEADACHE; HEARTBURN; HOT FLUSH; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CISAPRIDE; CISPLATIN; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NEOPLASMS; SEROTONIN AGONISTS; TREATMENT OUTCOME; VOMITING;

EID: 0035140871     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200000156     Document Type: Article

References (18)

1. Small intestinal mucosal toxicity of cisplatinum. Comparison of toxicity with platinum analogues and dexamethasone
2. Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the Perugia Consensus Conference
3. Drugs affecting serotonin receptors
4. Functional and structural changes of the human proximal small intestine after cytotoxic therapy
5. Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: A double-blind, placebo-controlled, comparative study
6. Potential for combination therapy with the new antiserotinergic agents
7. Prolonged nausea and vomiting after high dose chemotherapy and autologous peripheral stem cell transplantation in the treatment of high risk breast carcinoma
8. Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer
9. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis
10. Superior outcome of multiagent antiemetic regimens for chemotherapy (CT)-induced delayed nausea-vomiting (NV)
11. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin
12. Controlling delayed vomiting: Double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin
13. Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy
14. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist
15. Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: Neuropathological studies
16. Double-blind, multicenter, randomized trial to compare the effect of two doses of adrenocorticotropic hormone versus placebo in controlling delayed emesis after high-dose cisplatin in adult patients with cancer
17. Oral cisapride for the control of delayed vomiting following high-dose cisplatin
18. 3 antagonist action in the control of emesis